Romagna Alexander, Ladisich Barbara, Schwartz Christoph, Winkler Peter A, Rahman Al-Schameri Abdul
1 Division of Neurosurgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada (current address).
2 Department of Neurosurgery, Christian Doppler Medical Center, Paracelsus Private Medical University, Salzburg, Austria.
Interv Neuroradiol. 2019 Apr;25(2):144-149. doi: 10.1177/1591019918805774. Epub 2018 Oct 28.
The rate of intracranial aneurysm remnants/recurrences after microsurgical clipping varies widely. The optimal management for these patients remains a matter of debate. Repeat surgery in particular bears a high risk of periprocedural complications due to anatomical distortion from prior procedures. This study aims to evaluate the risk-benefit profile of flow-diverter stents in these patients.
The patient database of our neurovascular centre was queried to identify patients with clipped aneurysms who subsequently underwent endovascular treatment with intraluminal flow-diverter stents. The outcome analysis consisted of an assessment of clinical parameters (modified Rankin scale) and the post-interventional angiographic occlusion status (according to the Raymond-Roy occlusion classification).
Six patients underwent endovascular treatment with flow-diverter stents of recurrent aneurysms after clipping. Treatment was necessary in two patients due to progressive neurological deficits, and due to angiographic proof of an increasing aneurysm size in the other four patients. Median aneurysm size was 0.45 cm. All patients had a prior history of subarachnoid haemorrhage. The time from primary clipping to recurrence was 10.6 years. Complete radiological aneurysm occlusion was feasible in five out of six cases. Two patients who had experienced pre-interventional neurological deficits showed a complete remission of symptoms on last follow-up. No periprocedural morbidity or mortality was recorded and no patient required retreatment within the median follow-up.
This case series suggests that endovascular treatment with flow-diverter stents of aneurysm remnants after previous microsurgical clipping is a feasible treatment concept with a low-risk profile, which might prevent the treatment burden and risks of repeat surgery.
显微外科夹闭术后颅内动脉瘤残留/复发率差异很大。这些患者的最佳治疗方案仍存在争议。特别是再次手术因先前手术导致的解剖结构变形而具有较高的围手术期并发症风险。本研究旨在评估血流导向支架在这些患者中的风险效益情况。
查询我们神经血管中心的患者数据库,以确定接受过动脉瘤夹闭术且随后接受腔内血流导向支架血管内治疗的患者。结果分析包括对临床参数(改良Rankin量表)和介入后血管造影闭塞状态(根据Raymond-Roy闭塞分类)的评估。
6例患者在动脉瘤夹闭术后接受了复发性动脉瘤的血流导向支架血管内治疗。2例患者因进行性神经功能缺损而需要治疗,另外4例患者因血管造影证实动脉瘤大小增加而需要治疗。动脉瘤中位大小为0.45厘米。所有患者既往均有蛛网膜下腔出血病史。从初次夹闭到复发的时间为10.6年。6例中有5例实现了动脉瘤的完全放射学闭塞。2例术前有神经功能缺损的患者在最后一次随访时症状完全缓解。未记录到围手术期 morbidity 或死亡率,且在中位随访期内无患者需要再次治疗。
该病例系列表明,先前显微外科夹闭术后的动脉瘤残留采用血流导向支架进行血管内治疗是一种可行的治疗方案,风险较低,这可能避免再次手术的治疗负担和风险。